Panchsheel Organic Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 531726

₹103.10

Oct. 5, 2026 · BSE · bse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #132 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited	100,411	150.9	10.9%	-3.7%	—	62	33	71
Panchsheel Organic Ltd. (this stock)	136	13.2	8.7%	-51.5%	—	64	93	46

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹138 Cr

EV / EBITDA

8.4x

EV / Sales

1.28x

Market cap / Sales

1.26x

Earnings yield

7.58%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 25 Cr, up 4.0% YoY.

↓ Negative

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 2 Cr, down 18.7% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	25	3	2	₹1.7600
March 31, 2026	31	3	—	₹1.2900
Dec. 31, 2025	27	4	—	₹2.7900
Sept. 30, 2025	25	3	3	₹1.9800
June 30, 2025	24	4	3	₹2.1600
March 31, 2025	28	4	3	₹2.4100
Dec. 31, 2024	26	5	4	₹2.7900
Sept. 30, 2024	27	5	4	₹2.8800
June 30, 2024	26	5	3	₹2.6000
March 31, 2024	31	4	3	₹2.3400
Dec. 31, 2023	26	6	4	₹3.1500
Sept. 30, 2023	24	5	4	₹3.0200
June 30, 2023	25	5	3	₹2.8900

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	25	32	28	26	24	—	27	28	27	31	27	25	25
Operating revenue	25	31	27	25	24	28	26	27	26	31	26	24	25
Other income	1	1	1	1	1	—	1	1	1	0	1	1	0
Operating expenses	21	29	23	22	20	24	22	22	22	27	21	19	20
Operating profit	3	2	4	4	4	5	5	5	4	5	5	4	5
Operating profit margin	13.5%	7.8%	14.1%	13.8%	15.9%	16.8%	17.3%	18.9%	17.0%	15.1%	19.2%	18.7%	19.8%
Depreciation	1	1	1	1	1	1	1	1	1	1	0	0	0
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	3	3	4	3	4	4	5	5	5	4	6	5	5
Tax	1	1	0	1	1	1	1	1	1	1	1	1	1
Net profit	2	—	—	3	3	3	4	4	3	3	4	4	3
EPS	1.76	1.29	2.79	1.98	2.16	2.41	2.79	2.88	2.60	2.34	3.15	3.02	2.89
Net profit (TTM)	—	—	—	12	13	14	14	14	14	14	14	14	14
EPS (TTM)	7.82	8.22	9.34	9.34	10.24	10.68	10.61	10.97	11.11	11.40	11.59	11.77	12.27

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	1.9%	17.3%	110^†	—	108^†	104^†	69^†	50^†	51^†	49^†	—	—
Operating revenue	1.1%	16.6%	107^†	108^†	105^†	103^†	69^†	49^†	50^†	48^†	43^†	40^†
Other income	—	—	4^†	—	2^†	1^†	0^†	0^†	0^†	0^†	—	—
Operating expenses	—	—	93^†	89^†	86^†	83^†	56^†	41^†	42^†	41^†	36^†	33^†
Operating profit	-12.4%	9.2%	13^†	19^†	19^†	20^†	13^†	9^†	9^†	7^†	7^†	7^†
Operating profit margin	—	—	12.6%^†	17.5%^†	18.0%^†	19.4%^†	18.6%^†	17.5%^†	16.9%^†	14.4%^†	16.1%^†	17.4%^†
Depreciation	—	—	2^†	2^†	2^†	2^†	1^†	1^†	1^†	1^†	1^†	1^†
Interest	—	—	0^†	0^†	0^†	1^†	0^†	0^†	0^†	0^†	1^†	0^†
Exceptional items, gain / (loss)	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	-8.8%	14.7%	14^†	19^†	19^†	19^†	11^†	7^†	7^†	6^†	5^†	5^†
Tax	—	—	4^†	5^†	5^†	5^†	3^†	2^†	2^†	2^†	2^†	2^†
Net profit	—	—	—	14^†	14^†	14^†	8^†	5^†	5^†	4^†	4^†	3^†
EPS	-13.9%	-4.3%	8.22^†	10.68^†	11.40^†	12.86^†	11.63^†	10.22^†	10.82^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	12.6%^†	17.5%^†	18.0%^†	19.4%^†	18.6%^†	17.5%^†	16.9%^†	14.4%^†	16.1%^†	17.4%^†
EBIT margin	13.8%^†	17.7%^†	18.7%^†	19.0%^†	16.9%^†	15.6%^†	15.1%^†	12.5%^†	13.4%^†	13.7%^†
PBT margin	13.6%^†	17.3%^†	18.4%^†	18.5%^†	16.5%^†	14.7%^†	14.5%^†	11.7%^†	12.2%^†	12.5%^†
Net margin	—	13.0%^†	13.4%^†	13.6%^†	12.1%^†	10.1%^†	10.5%^†	8.4%^†	8.6%^†	8.0%^†
Interest coverage	53.52x^†	51.16x^†	73.51x^†	35.89x^†	40.47x^†	17.94x^†	24.84x^†	15.61x^†	10.65x^†	11.23x^†
Dividend payout	0.0%^†	0.0%^†	0.0%^†	0.0%^†	0.0%^†	0.0%^†	0.0%^†	—	—	—
Earnings retention	100.0%^†	100.0%^†	100.0%^†	100.0%^†	100.0%^†	100.0%^†	100.0%^†	—	—	—
Current ratio	3.40x	3.65x	—	—	—	—	—	—	—	—
Quick ratio	1.69x	1.76x	—	—	—	—	—	—	—	—
Debt to equity	0.04x	0.04x	—	—	—	—	—	—	—	—
Return on equity	—	10.5%^†	—	—	—	—	—	—	—	—
Return on assets	—	8.6%^†	—	—	—	—	—	—	—	—
Return on capital employed	10.1%^†	13.7%^†	—	—	—	—	—	—	—	—
Asset turnover	0.62x^†	0.66x^†	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	10	-7	-4	7	3
March 31, 2025	4	-16	-5	16	-12

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	172	141	128	6	0	90	26	4	20	45
March 31, 2025	163	134	121	5	0	89	24	4	18	46

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.